This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionLast revisionBoth sides next revision | ||
home:diseases [02.22.2019] – [Microbial communication] sallieq | home:diseases [05.29.2020] – sallieq | ||
---|---|---|---|
Line 9: | Line 9: | ||
Some diseases are represented by more patients trying the therapy than others. As more patients join the MP cohort, the Autoimmunity Research Foundation will gather more data about the efficacy of the treatment with respect to individual diseases. In the meantime, the MP may be an appropriate treatment option for some of the diseases listed below. | Some diseases are represented by more patients trying the therapy than others. As more patients join the MP cohort, the Autoimmunity Research Foundation will gather more data about the efficacy of the treatment with respect to individual diseases. In the meantime, the MP may be an appropriate treatment option for some of the diseases listed below. | ||
- | [[home: | + | [[home: |
===== What is a chronic inflammatory disease? ===== | ===== What is a chronic inflammatory disease? ===== | ||
Line 43: | Line 43: | ||
The contribution of cell-cell signaling and motility to bacterial biofilm formation. | The contribution of cell-cell signaling and motility to bacterial biofilm formation. | ||
- | |||
- | |||
- | Bacteria-triggered release of antimicrobial agents. | ||
- | }})) | ||
| | ||
- | | + | Bacterial Biofilm Control by Perturbation of Bacterial Signaling Processes.(({{pubmed> |
| | ||
- | (({{pubmed> | + | |
===== List of diseases ===== | ===== List of diseases ===== |